Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.
तुलना करने के लिए मीट्रिक्स | PARNF | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधPARNFपीअर्सक्षेत्र | |
---|---|---|---|---|
पी/ई अनुपात | 0.0x | −1.9x | −0.5x | |
PEG अनुपात | 0.00 | 0.00 | 0.00 | |
क़ीमत/बुक | 0.0x | 1.5x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 0.0x | 8.3x | 3.0x | |
अपसाइड (विश्लेषक लक्ष्य) | 0.0% | 214.3% | 56.4% | |
उचित मूल्य अपसाइड | अनलॉक करें | 16.3% | 9.9% | अनलॉक करें |